Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16755363 | 1.00 | POLB (0.37) | POLBHPGDALDH1A1TAAR1FFAR1 | |
| SCHEMBL28574203 | 0.98 | POLB (0.36) | POLBHPGDALDH1A1TAAR1FFAR1 | |
| SCHEMBL7118503 | 0.86 | POLB (0.33) | POLBCA2CAMK2A | |
| SCHEMBL11580290 | 0.82 | FFAR1 (0.39) | HPGDALDH1A1TAAR1FFAR1GAA | |
| SCHEMBL28574202 | 0.82 | ALDH1A1 (0.33) | POLBHPGDALDH1A1TAAR1EPHX1 | |
| SCHEMBL11580683 | 0.78 | KEAP1 (0.35) | HPGDFFAR1NPSR1THRATHRB | |
| SCHEMBL971269 | 0.76 | ALDH1A1 (0.47) | POLBHPGDALDH1A1TAAR1FFAR1 | |
| SCHEMBL28255697 | 0.76 | — | — | |
| SCHEMBL6561152 | 0.76 | ALDH1A1 (0.32) | POLBHPGDALDH1A1TAAR1 | |
| SCHEMBL10568010 | 0.75 | ALDH1A1 (0.46) | POLBHPGDALDH1A1TAAR1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9714201-B2 | Isononylamines from 2-ethylhexanol, processes for their preparation, and their use | OXEA GMBH (DE) | 2017-07-25 | — | — | US | disclosed |
| US-9334225-B2 | Vinyl esters of isononanoic acid starting from 2-ethyl hexanol, methods for the production thereof and use thereof | OXEA GMBH (DE) | 2016-05-10 | — | — | US | disclosed |
| US-20150166456-A1 | Vinyl Esters of Isononanoic Acid Starting from 2-Ethyl Hexanol, Methods for the Production Thereof and Use Thereof | OXEA GMBH (DE) | 2015-06-18 | — | — | US | disclosed |
| US-20150152023-A1 | Isononylamines from 2-Ethylhexanol, Processes for Their Preparation, and Their Use | OXEA GMBH (DE) | 2015-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166456-A1 | Vinyl Esters of Isononanoic Acid Starting from 2-Ethyl Hexanol, Methods for the Production Thereof and Use Thereof | FASN, HSD17B12, ELOVL1 | POLB 1258/4885HPGD 67/4885ALDH1A1 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.